Co-Diagnostics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 1.78 M | $2.23 M | 0.00% | 5.84% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 567,722 | $709,653 | -3.28% | 1.86% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 504,382 | $630,478 | 100.00% | 1.65% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 321,275 | $401,692 | 1.23% | 1.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 272,900 | $341,125 | 0.00% | 0.89% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 187,569 | $234,461 | -6.95% | 0.62% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 137,068 | $171,335 | 0.00% | 0.45% |
KESTRA ADVISORY SERVICES, LLC | 11/13/2024 | 127,941 | $159,926 | -14.63% | 0.42% |
STATE STREET CORP | 11/14/2024 | 100,647 | $125,809 | 0.00% | 0.33% |
KOSS-OLINGER CONSULTING, LLC | 10/21/2024 | 58,102 | $73,000 | -1.33% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 46,600 | $58,250 | -60.58% | 0.15% |
JANE STREET GROUP, LLC | 11/15/2024 | 44,124 | $55,155 | 100.00% | 0.14% |
THOMPSON DAVIS & CO., INC. | 11/08/2024 | 41,500 | $51,875 | 0.00% | 0.14% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 40,075 | $50,094 | 51.55% | 0.13% |
PHYSICIAN WEALTH ADVISORS, INC. | 10/16/2024 | 28,375 | $35,753 | -9.56% | 0.09% |
SMI ADVISORY SERVICES, LLC | 10/07/2024 | 28,000 | $35,840 | 0.00% | 0.09% |
GTS SECURITIES LLC | 11/13/2024 | 27,400 | $34,250 | 100.00% | 0.09% |
CITADEL ADVISORS LLC | 11/14/2024 | 25,423 | $31,779 | -52.72% | 0.08% |
MORGAN STANLEY | 11/14/2024 | 14,537 | $18,172 | -28.06% | 0.05% |
UBS GROUP AG | 11/14/2024 | 12,773 | $15,966 | -43.34% | 0.04% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 12,440 | $15,550 | 0.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 11,700 | $14,625 | 100.00% | 0.04% |
VIRTU FINANCIAL LLC | 11/20/2024 | 11,029 | $14,000 | -60.48% | 0.04% |
SIMPLEX TRADING, LLC | 11/08/2024 | 10,736 | $13,000 | -83.44% | 0.04% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 10,542 | $13,178 | 0.00% | 0.03% |
CITADEL ADVISORS LLC | 11/14/2024 | 9,100 | $11,375 | 175.76% | 0.03% |
CITADEL ADVISORS LLC | 11/14/2024 | 6,700 | $8,375 | 67.50% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,882 | $6,102 | -7.40% | 0.02% |
CAPITAL PERFORMANCE ADVISORS LLP | 11/01/2024 | 4,000 | $5,000 | 100.00% | 0.01% |
GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 3,000 | $3,750 | 0.00% | 0.01% |
CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 1,661 | $2,076 | 0.00% | 0.01% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1,341 | $1,676 | 419.77% | 0.00% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 1,175 | $1,469 | 327.27% | 0.00% |
HERITAGE WEALTH ADVISORS | 11/12/2024 | 525 | $656 | 0.00% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 200 | $250 | 0.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 11/14/2024 | 200 | $250 | 0.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 100 | $125 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 12/26/2024 | 76 | $95 | 0.00% | 0.00% |
WOLVERINE TRADING, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
GTS SECURITIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
ENGINEERS GATE MANAGER LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
PEAK6 INVESTMENTS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
TOWNSQUARE CAPITAL LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
FINANCIAL NETWORK WEALTH ADVISORS LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
Co-Diagnostics, Inc.institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of Co-Diagnostics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.78 M
RENAISSANCE TECHNOLOGIES LLC: 567,722
BlackRock Funding, Inc. /DE: 504,382
GEODE CAPITAL MANAGEMENT, LLC: 321,275
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 272,900
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 187,569
14.47% of Co-Diagnostics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.35 M shares in the last 24 months. This purchase volume represents approximately $4.23 M in transactions.